Malin Life Sciences Holdings Ltd is 10% Owner at Poseida Therapeutics, Inc. (PSTX). They have made 7 open-market trades across 2 companies since 2019, most recently 2025-01-08.
CIK 0001685138
6 open-market purchases totalling $14.6M since 2021, against 1 sale. Across 6 scored buys the stock is down 39.6% at ninety days, and 32.4 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 0% | 17% |
| Avg Move | -5.2% | -4.6% | -39.6% |
| Alpha | -3.9% | -4.8% | -32.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PSTX | BUY | 2022-08-08 | 2022-08-10 | $3.50 | $7.5M | -7.4% | -6.3% | +13.7% |
| PSTX | BUY | 2021-12-06 | 2021-12-07 | $6.90 | $13K | -0.9% | -9.1% | -53.3% |
| PSTX | BUY | 2021-11-30 | 2021-12-02 | $6.85 | $673K | -11.0% | -6.4% | -56.5% |
| PSTX | BUY | 2021-11-24 | 2021-11-29 | $6.83 | $531K | +3.3% | -0.7% | -47.6% |
| PSTX | BUY | 2021-11-19 | 2021-11-23 | $7.06 | $363K | -6.6% | +0.0% | -49.9% |
| PSTX | BUY | 2021-11-16 | 2021-11-18 | $7.20 | $5.5M | -8.9% | -5.2% | -43.9% |
| NOVN | SELL | 2019-06-28 | 2019-07-02 | $2.71 | $68K | -0.3% | -13.4% | -11.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.